|
|
immune effector process
|
GO:0002252 |
321 |
0.572
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.471
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.432
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.418
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.409
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.378
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.357
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.294
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.291
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.272
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.262
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.261
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.255
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.250
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.230
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.227
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.222
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.221
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.217
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.210
|
|
|
|
eosinophil activation
|
GO:0043307 |
1 |
0.201
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.196
|
|
|
|
hematopoietic stem cell migration
|
GO:0035701 |
1 |
0.188
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.187
|
|
|
|
leukocyte degranulation
|
GO:0043299 |
27 |
0.183
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.173
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.172
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.163
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.163
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.161
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.160
|
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.153
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.153
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.151
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.151
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.149
|
|
|
|
positive regulation of monocyte extravasation
|
GO:2000439 |
1 |
0.147
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.147
|
|
|
|
cd8 positive alpha beta t cell extravasation
|
GO:0035697 |
3 |
0.145
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.145
|
|
|
|
helper t cell chemotaxis
|
GO:0035704 |
1 |
0.145
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.144
|
|
|
|
negative regulation of eosinophil degranulation
|
GO:0043310 |
1 |
0.144
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.144
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.138
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.137
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.136
|
|
|
|
regulation of monocyte extravasation
|
GO:2000437 |
2 |
0.130
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.130
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.129
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.126
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation
|
GO:2000721 |
2 |
0.124
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.122
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.121
|
|
|
|
positive regulation of t cell costimulation
|
GO:2000525 |
2 |
0.120
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.114
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.114
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.114
|
|
|
|
regulation of cd8 positive alpha beta t cell extravasation
|
GO:2000449 |
3 |
0.112
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.111
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.111
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.109
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.108
|
|
|
|
cellular extravasation
|
GO:0045123 |
17 |
0.108
|
|
|
|
microglial cell activation involved in immune response
|
GO:0002282 |
1 |
0.107
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.106
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.105
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.105
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.103
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.103
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.103
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.102
|
|
|
|
t cell extravasation
|
GO:0072683 |
4 |
0.102
|
|
|
|
regulation of hematopoietic stem cell migration
|
GO:2000471 |
1 |
0.102
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.102
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.101
|
|
|
|
eosinophil mediated immunity
|
GO:0002447 |
1 |
0.100
|
|
|
|
regulation of immune complex clearance by monocytes and macrophages
|
GO:0090264 |
2 |
0.099
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.099
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.098
|
|
|
|
regulation of eosinophil degranulation
|
GO:0043309 |
1 |
0.097
|
|
|
|
microglia development
|
GO:0014005 |
2 |
0.097
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.096
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.096
|
|
|
|
neutrophil migration
|
GO:1990266 |
37 |
0.095
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.095
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.095
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.095
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.094
|
|
|
|
positive regulation of t cell receptor signaling pathway
|
GO:0050862 |
4 |
0.094
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.094
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.092
|
|
|
|
chemokine mediated signaling pathway
|
GO:0070098 |
17 |
0.092
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.090
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.090
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.090
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.090
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.089
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.089
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.088
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.088
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.087
|
|
|
|
positive regulation of t cell extravasation
|
GO:2000409 |
2 |
0.087
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.086
|
|
|
|
eosinophil activation involved in immune response
|
GO:0002278 |
1 |
0.086
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.085
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.084
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.083
|
|
|
|
t helper 17 cell chemotaxis
|
GO:0035705 |
1 |
0.082
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.082
|
|
|
|
regulation of t cell costimulation
|
GO:2000523 |
2 |
0.081
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.081
|
|
|
|
positive regulation of hematopoietic stem cell migration
|
GO:2000473 |
1 |
0.080
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.080
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.079
|
|
|
|
monocyte extravasation
|
GO:0035696 |
2 |
0.079
|
|
|
|
eosinophil degranulation
|
GO:0043308 |
1 |
0.079
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.078
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.078
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.078
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.077
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.077
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.077
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.076
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.076
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.075
|
|
|
|
immune complex clearance by monocytes and macrophages
|
GO:0002436 |
2 |
0.075
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.075
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.075
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.074
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.074
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.073
|
|
|
|
lymphocyte migration
|
GO:0072676 |
26 |
0.073
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.072
|
|
|
|
thymic t cell selection
|
GO:0045061 |
22 |
0.072
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.069
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.069
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.069
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.068
|
|
|
|
microglia differentiation
|
GO:0014004 |
2 |
0.068
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.068
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.068
|
|
|
|
regulation of t cell extravasation
|
GO:2000407 |
3 |
0.068
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.067
|
|
|
|
positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation
|
GO:2000526 |
1 |
0.066
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.065
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.064
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.064
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.064
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.063
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.063
|
|
|
|
myeloid cell activation involved in immune response
|
GO:0002275 |
34 |
0.062
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.062
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.062
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.062
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.062
|
|
|
|
positive regulation of dendritic cell chemotaxis
|
GO:2000510 |
1 |
0.061
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.061
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.061
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.061
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.061
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.061
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.061
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.060
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.060
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.060
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.060
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.060
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.060
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.059
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.059
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.059
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.058
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.058
|
|
|
|
positive regulation of immunological synapse formation
|
GO:2000522 |
1 |
0.058
|
|
|
|
immune complex clearance
|
GO:0002434 |
2 |
0.057
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.057
|
|
|
|
interleukin 12 secretion
|
GO:0072610 |
3 |
0.057
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.056
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.055
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.055
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.055
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.055
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.054
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.054
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.054
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.053
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.053
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.053
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.053
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.052
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.052
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.052
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.052
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.051
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.051
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.050
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.050
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.050
|
|
|
|
regulation of dendritic cell chemotaxis
|
GO:2000508 |
1 |
0.050
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.050
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.050
|
|
|
|
neutrophil chemotaxis
|
GO:0030593 |
36 |
0.050
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.049
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.049
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.049
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.049
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.049
|
|
|
|
positive regulation of cd8 positive alpha beta t cell extravasation
|
GO:2000451 |
2 |
0.048
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.048
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.048
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.047
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.047
|
|
|
|
positive regulation of cytokine biosynthetic process
|
GO:0042108 |
40 |
0.047
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.047
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.047
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.047
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.047
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.047
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.046
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.046
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.046
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.046
|
|
|
|
acute inflammatory response to antigenic stimulus
|
GO:0002438 |
12 |
0.046
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.045
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.045
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.045
|
|
|
|
positive regulation of monocyte chemotaxis
|
GO:0090026 |
2 |
0.045
|
|
|
|
positive regulation of interferon gamma production
|
GO:0032729 |
39 |
0.045
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.045
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.045
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.045
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.045
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.044
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.044
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.044
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.044
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.044
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.044
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.043
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.043
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.043
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.043
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.042
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.042
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.042
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.042
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.041
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.041
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.041
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.041
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.040
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.040
|
|
|
|
regulation of osteoblast proliferation
|
GO:0033688 |
15 |
0.040
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.040
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.040
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.040
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.040
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.039
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.039
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.039
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.039
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.038
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.038
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.038
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.038
|
|
|
|
regulated secretory pathway
|
GO:0045055 |
32 |
0.038
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.037
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.037
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.037
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.037
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.037
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.036
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.036
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.036
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.036
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.036
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.036
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.036
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.036
|
|
|
|
negative regulation of signal transduction in absence of ligand
|
GO:1901099 |
16 |
0.036
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.036
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.036
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.036
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.036
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.035
|
|
|
|
sphingosine 1 phosphate signaling pathway
|
GO:0003376 |
3 |
0.035
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.035
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.035
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.035
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.035
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.035
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.034
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.034
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.034
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.034
|
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.034
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.034
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.034
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.034
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.034
|
|
|
|
negative regulation of rho protein signal transduction
|
GO:0035024 |
7 |
0.034
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.033
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.033
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.033
|
|
|
|
filopodium assembly
|
GO:0046847 |
19 |
0.033
|
|
|
|
protein citrullination
|
GO:0018101 |
2 |
0.032
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.032
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.032
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.032
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.032
|
|
|
|
cardiac muscle tissue growth involved in heart morphogenesis
|
GO:0003245 |
1 |
0.032
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.032
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.032
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.032
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.032
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.032
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.032
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.032
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.032
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.032
|
|
|
|
negative regulation of ras protein signal transduction
|
GO:0046580 |
18 |
0.031
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.031
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.031
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.031
|
|
|
|
positive regulation of immune complex clearance by monocytes and macrophages
|
GO:0090265 |
2 |
0.031
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.031
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.031
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.031
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.031
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.031
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.031
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.031
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.030
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.030
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.030
|
|
|
|
fucosylation
|
GO:0036065 |
9 |
0.030
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.030
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.030
|
|
|
|
dendritic spine maintenance
|
GO:0097062 |
4 |
0.030
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.030
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.029
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.029
|
|
|
|
tolerance induction to self antigen
|
GO:0002513 |
4 |
0.029
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.029
|
|
|
|
regulation of antigen receptor mediated signaling pathway
|
GO:0050854 |
29 |
0.029
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.029
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.029
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.029
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.029
|
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
26 |
0.029
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.029
|
|
|
|
t cell migration
|
GO:0072678 |
19 |
0.028
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.028
|
|
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.028
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.028
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.028
|
|
|
|
positive regulation of tumor necrosis factor production
|
GO:0032760 |
30 |
0.028
|
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.028
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.027
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.027
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.027
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.027
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.027
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.027
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.027
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.027
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.027
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.027
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.027
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.027
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.027
|
|
|
|
regulation of calcium mediated signaling
|
GO:0050848 |
19 |
0.026
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.026
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.026
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.026
|
|
|
|
negative regulation of myeloid leukocyte differentiation
|
GO:0002762 |
20 |
0.026
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.026
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.026
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.026
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.026
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.026
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.026
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.026
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.026
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.026
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.026
|
|
|
|
positive regulation of b cell activation
|
GO:0050871 |
49 |
0.026
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.026
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.025
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.025
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.025
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.025
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.025
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.025
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.025
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.025
|
|
|
|
positive regulation of osteoblast proliferation
|
GO:0033690 |
9 |
0.025
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.025
|
|
|
|
osteoblast proliferation
|
GO:0033687 |
18 |
0.025
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.025
|
|
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.025
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.025
|
|
|
|
regulation of regulated secretory pathway
|
GO:1903305 |
20 |
0.025
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.025
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.025
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.025
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.024
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.024
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.024
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.024
|
|
|
|
mast cell activation involved in immune response
|
GO:0002279 |
20 |
0.024
|
|
|
|
negative regulation of leukocyte mediated immunity
|
GO:0002704 |
29 |
0.024
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.024
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.024
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.024
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.024
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.024
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.024
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.024
|
|
|
|
somatic diversification of immunoglobulins
|
GO:0016445 |
43 |
0.023
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.023
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.023
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.023
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.023
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.023
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.023
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.023
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.023
|
|
|
|
interleukin 1 beta production
|
GO:0032611 |
30 |
0.023
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.023
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.023
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.023
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.023
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.023
|
|
|
|
negative regulation of myeloid leukocyte mediated immunity
|
GO:0002887 |
7 |
0.022
|
|
|
|
positive regulation of osteoclast differentiation
|
GO:0045672 |
15 |
0.022
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.022
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.022
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.022
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.022
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.022
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.022
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.022
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.022
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.022
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.022
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.022
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.022
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.022
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.022
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.022
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.022
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.022
|
|
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.022
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.022
|
|
|
|
negative regulation of regulated secretory pathway
|
GO:1903306 |
7 |
0.022
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.022
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.021
|
|
|
|
somatic recombination of immunoglobulin gene segments
|
GO:0016447 |
42 |
0.021
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.021
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.021
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.021
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.021
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.021
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.021
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.021
|
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.021
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.021
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.021
|
|
|
|
interleukin 1 beta secretion
|
GO:0050702 |
16 |
0.021
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.021
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.021
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.021
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.021
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.021
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.021
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.020
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.020
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.020
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.020
|
|
|
|
regulation of myeloid leukocyte mediated immunity
|
GO:0002886 |
25 |
0.020
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.020
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.020
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.020
|
|
|
|
regulation of excitatory postsynaptic membrane potential
|
GO:0060079 |
41 |
0.020
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.020
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.020
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.020
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.020
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.020
|
|
